389 Combining Transcriptomic- and Tissue-Based Immune Biomarkers to Evaluate GB1275, a CD11b Modulator, As a Single Agent or with Pembrolizumab in Patients with Advanced Solid Tumors
Regular and Young Investigator Award Abstracts（2020）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined